Psorospermin is a
natural product that has been shown to have activity against
drug-resistant
leukemia lines and
AIDS-related lymphoma. It has also been shown to alkylate
DNA through an
epoxide-mediated electrophilic attack, and this alkylation is greatly enhanced at specific sites by
topoisomerase II. In this article, we describe the synthesis of the two diastereomers of O5-methyl
psorospermin and their in vitro activity against a range of solid and hematopoietic
tumors. The diastereomeric pair (+/-)-(2'R,3'R) having the naturally occurring enantiomer (2'R,3'R) is the most active across all the cell lines and shows approximately equal activity in both
drug-sensitive and
drug-resistant cell lines. In subsequent studies using all four enantiomers of O5-methyl
psorospermin, the order of
biological potency is (2'R,3'R) > (2'R,3'S) = (2'S,3'R) > (2'S,3'S). This order of potency is also found in the
topoisomerase II-induced alkylation of O5-methyl
psorospermin and can be rationalized by molecular modeling of the
psorospermin-duplex binding complex. Therefore, this study defines the optimum stereochemical requirements for both the
topoisomerase II-induced alkylation of
DNA and the
biological activity by
psorospermin and its O5-methyl derivatives. Finally, (2'R,3'R)
psorospermin was found to be as effective as
gemcitabine in slowing
tumor growth in vivo in a MiaPaCa
pancreatic cancer model. In addition, (2'R,3'R)
psorospermin in combination with
gemcitabine was found to show an at least additive effect in slowing
tumor growth of MiaPaCa.